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New developments in technology usually entail some hazard as well as advantage to a society.
Hazard of a material translates into risk by exposure of humans and/or their environment to
the agent in question, and risk is reduced by control of exposure, usually guided by regulation
based on understanding of the mechanisms of harm. We illustrate risks relating to the causa-
tion of diseases associated with exposure to aerosols of combustion particles and asbestos,
leading to paradigms of particle toxicity, and discuss analogies with potential exposure to
manufactured nanoparticles (NPs). We review the current understanding of the hazard of
NPs derived from the new science of nanotoxicology and the limited research to date into
human exposure to these particles. We identify gaps in knowledge relating to the properties
of NPs that might determine toxicity and in understanding the most appropriate ways both
to measure this in the laboratory and to assess it in the workplace. Nevertheless, we point out
that physical principles governing the behaviour of such particles allow determination of prac-
tical methods of protecting those potentially exposed. Finally, we discuss the early steps
towards regulation and the difﬁculties facing regulators in controlling potentially harmful
exposures in the absence of sufﬁcient scientiﬁc evidence.
Keywords: nanoparticles; toxicological hazard; measurement; regulation1. INTRODUCTION
It is probable that the introduction of all new technol-
ogies will have unexpected consequences, both
beneﬁcial and harmful. In a democratic society, the
business of regulation is to reduce risks from the latter
while not inhibiting the development of the former.
Scientiﬁc evidence plays a major role, often misunder-
stood by the media and even by some scientists, in
the process of regulation. Indeed ‘health and safety’
has become an easy excuse for the prevention of
desirable activities by those unable or unwilling to
understand the process.
Public awareness of nanotechnologies is now increas-
ing rapidly, largely as a consequence of non-speciﬁcally
regulated introduction of products containing nano-
materials into the marketplace. Self-cleaning windows,
stain-resistant clothes and better tennis racquets areaddress for correspondence: 8 Avon Grove, Edinburgh
(a.seaton@abdn.ac.uk).
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individuals to dose themselves with tonics containing
nanosilver in the belief that this will prevent infections.
The fear that nanotechnologies would be seriously
hindered, as previously had those involving genetic
modiﬁcation, by the alarms sounded by pressure groups
hinting at grey goo and human enhancement has now lar-
gely been set aside, and their entrepreneurial development
is proceeding apace. Nevertheless, it is important to heed
the advice given to government in 2005 by the working
group of the Royal Society and the Royal Academy of
Engineering (Royal Society and Royal Academy of
Engineering 2004). Thismay be summarized as indicating
that nanotechnologies present great opportunities but
that it is also possible to foresee some hazards, which
should be taken account of by research on which regu-
lation might be based. The nature of such research must
be interdisciplinary. In this paper, we discuss this research
and summarize where we stand today with respect to
translating this into regulation to ensure that those
making, using and disposing of nanomaterials are
protected as far as practicable from injury.This journal is # 2009 The Royal Society
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It is appropriate to start with a warning. Two toxic sub-
stances stand out above all others in the history of
peacetime technology in terms of deaths caused:
quartz and asbestos. In the former case, the harmful-
ness of inhaling ﬁne particles was recognized in the
eighteenth century and in the latter at the end of
the nineteenth century. In both cases, physicians and
scientists were intrigued by the possibility of under-
standing the mechanisms of toxicity, an area of
investigation that attracted support from the industries
concerned, driven by the medical mindset that if a
mechanism can be found, then a cure may follow. In
both cases, appropriate epidemiological research to associ-
ate exposure and effect was long delayed, effective
regulation and enforcement were not introduced and
workers continued to die (and still do). The industries
concerned proved resistant to funding this research. The
warning is this: it is not necessary to understand mechan-
isms before taking steps to prevent an occupational or
environmental disease, and too great a focus on mechan-
isms alone, though scientiﬁcally interesting, may distract
from applying preventive measures.
The concept that nanoparticles (NPs) may have
unique toxic properties is a recent one, though the
thinking behind it is derived from classical particle toxi-
cology and epidemiology, especially from studies of air
pollution. The harmfulness of air pollution was
suspected in the reign of Charles II but its real cost in
lives lost became clear in the 1930s and 1940s with
two episodes, one in the Meuse valley in Belgium and
the other in Donora in Pennsylvania. Coal smoke and
a winter temperature inversion were a lethal combi-
nation (McDonald et al. 1951). These episodes were
followed by the infamous London smog of December
1952 in which some 4000 excess deaths occurred over
a week. These deaths mostly appeared to be from lung
disease, chronic bronchitis being then a highly preva-
lent condition in urban Britain, but it was apparent
that a proportion was from heart attacks. Unusually,
this is an example of regulation occurring promptly
(cynics would argue that this was because the episode
centred on the Houses of Parliament), and the Clean
Air Acts were introduced and proved very effective in
reducing pollution while argument continued as to
which components of pollution, gases, acid aerosols or
solid particles were responsible. In addition to effective
regulation, research was funded by the UK Government
at the MRC air pollution unit in St Bartholomew’s
Medical School, and among the unit’s many achieve-
ments was the demonstration that over half of the
particles in London smog were less than 0.1 mm in
diameter (Lawther et al. 1968). The signiﬁcance of
this observation went largely unnoticed for 25 years,
but in the 1990s two separate lines of research
converged: epidemiological studies demonstrated
associations between deaths and particulate air pol-
lution even at extraordinarily low mass concentrations
(Pope et al. 1992; Schwartz 1994) and studies of depo-
sition of inhaled particles in the lungs of rats led to
the observation that particles in the nanosize range
were retained in the lungs and translocated to theJ. R. Soc. Interface (2010)interstitial tissues more readily than larger particles
(Ferin et al. 1992). We pointed out that the majority
of deaths associated with air pollution in the epidemio-
logical studies were from cardiac rather than respiratory
disease and attempted to explain the apparent fact that
toxicologically tiny doses of particulate matter (PM),
mainly carbon, to the lungs could cause death from fail-
ure of another organ by proposing the hypothesis that
the effect was a consequence not of the mass of particles
but of the number. We suggested that such particles
evaded the lungs’ primary defence, the macrophage,
and caused inﬂammation in the interstitial space
leading to release of cytokines and alteration of the
coagulability of the blood (Seaton et al. 1995). This
rather complex idea, generally called the ultraﬁne
hypothesis, triggered a change in the way toxicologists
were to investigate air pollution, with an emphasis on
the role of particles in the nanosize range.
Even more importantly in terms of the number of
individuals affected, longitudinal epidemiological
studies have shown that the intensity of population
exposure to air pollution in the past is related to the
risk of later death from heart disease in that population
(Dockery et al. 1993; Pope et al. 1995), suggesting that
air pollution, like cigarette smoking, is a risk factor for
the development of coronary artery disease and thus by
implication of atheroma, the disease process in arterial
walls that results in their progressive obstruction.
Atheromatous plaques rupture, releasing their contents
and precipitating thrombosis and the acute coronary
syndrome. As there is good evidence that inﬂammation
is involved in atherogenesis, cross-talk between pulmon-
ary inﬂammation caused by particles and inﬂammatory
activity in the plaques leading to their rupture may be
invoked to explain this association.
Over the same period that scientists have investi-
gated air pollution, there has been an analogous interest
in the toxicity of asbestos. From the early twentieth
century, it has been recognized that workers exposed
to this mineral ran excessive risks of the development
of ﬁbrosis of the lungs and, from the 1950s and 1960s,
of lung cancer and the pleural tumour mesothelioma.
The epidemiological research relating to the risks of
mesothelioma led to the conclusion that it would be
virtually impossible to prevent this disease unless the
importation and use of asbestos were prohibited.
However, asbestos was a very useful material and
many materials with similar properties were necessary
for industry. Thus, the toxicological research, initially
carried out to understand why this chemically inert
mineral had such devastating effects on the health of
those inhaling it (Mossman et al. 1990), became
relevant to the investigation of possible hazards from
substitute ﬁbrous minerals (Miller et al. 1999). This
led to the development of what became known as the
ﬁbre paradigm.3. PARADIGMS OF TOXICITY
3.1. The ultraﬁne hypothesis
There is not yet convincing epidemiological evidence
that the toxic component of particulate air pollution
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recent study in London reported to the Government’s
Committee on Medical Effects of Air Pollution
(R. Atkinson 2009, personal communication) has
suggested that particle count, which reﬂects the sub-
100 nm component, is the metric that best relates to
the risk of heart attack. Another approach has been
to investigate cardiac consequences of particulate
pollution in mechanistic terms and these studies have
indicated associations with rises in indices of inﬂam-
mation and in some cases falls in red blood cell
counts, suggesting activation of the endothelial cells
that line blood vessels (Seaton et al. 1999; Donaldson
et al. 2001). Human inhalation studies have used
diesel particles to investigate possible cardiac effects
and have shown low concentrations to be able to
cause release of vasomotor factors that may be relevant
to control of the coronary arteries. A sequence of studies
has identiﬁed an association between exposure to com-
bustion-derived NPs of diesel soot and cardiovascular
effects that are linked to atherothrombosis, the leading
cause of cardiovascular death in the populations at risk
from increases in PM. When exposed to dilute diesel
exhaust in chambers during exercise, healthy volunteers
demonstrated an early impairment of vascular function
that persisted for up to 24 h (Mills et al. 2005). This
vascular dysfunction seems to involve nitric oxide
pathways; reduced nitric oxide bioavailability as a con-
sequence of oxidative stress has been advanced as a
potential mechanism. In vitro studies have conﬁrmed
the release of superoxide from diesel particles as poten-
tial arbiters of adverse vascular effects and suggest that
exposure to PM could contribute to a hypertensive
phenotype (Auchincloss et al. 2008; Miller et al.
2009). Moving closer to the at-risk population, patients
with stable coronary artery disease were exposed to
dilute diesel exhaust (300 mg m23) during intermittent
exercise and the acute release of tissue plasminogen
activator, a key regulator of endogenous ﬁbrinolytic
capacity, was shown to be reduced after diesel exhaust
inhalation (Mills et al. 2007). The extent of this
reduction was comparable to that seen in cigarette
smokers. The clinical effect of diesel exposure was
further examined in patients with coronary heart dis-
ease. When patients were exposed to diesel exhaust,
myocardial ischaemia was quantiﬁed by ST-segment
analysis using continuous 12-lead electrocardiography
and a threefold greater increase in ischaemia was evi-
dent during exposure to diesel exhaust than during
exposure to ﬁltered air (Mills et al. 2007). Ex vivo
thrombus formation has also been assessed, using a
Badimon chamber, after controlled exposures to dilute
diesel exhaust. The Badimon chamber measures throm-
bus formation triggered by exposure to porcine aorta
denuded of its endothelium in extracorporeal whole
blood, under ﬂow conditions that mimic those found in
diseased coronary arteries. Within 2 h of dilute diesel
exhaust exposure, thrombus formation was enhanced
and associated with increased platelet activation
(Lucking et al. 2008). In studies where the particles were
ﬁltered out and exposure was only to the gases, there
was no effect, conﬁrming the role of the particles. Taken
together, these studies forge a clear link between exposureJ. R. Soc. Interface (2010)to combustion-derived particles and atherothrombosis. It
is accepted that these studies include exposure to particles
of greater than nanodimensions, but, on the reasonable
assumption that toxicity depends on surface area and
reactivity, the greatest toxicity will be found in the huge
numbers of small particles.
Associations with exposure to air pollution particles in
epidemiological studies of the clotting factors ﬁbrinogen
and factor VII have been equivocal, perhaps relating
to the time of sampling of what is a dynamic system
involving production and consumption of these factors.
There is, however, in vitro evidence of expression of the
clotting factor, tissue factor, and reduction in the clot
disrupting factor, plasminogen activator, in response to
air pollution particles (Gilmour et al. 2005).3.2. Transgression of biological membranes:
the role of size and shape
An NP may for practical purposes be characterized as
having at least one dimension less than 100 nm. Thus,
nanotubes and nanoﬁbres may be many micrometres
in length and only a few nanometres in diameter.
Many asbestos ﬁbres and ﬁbrils conform to this
deﬁnition. The ﬁbrogenicity and carcinogenicity of
asbestos is now very well known and much research
has led to the conclusion that this human toxicity is
related primarily to four factors:
(i) a length greater than about 15 mm, below which
the ﬁbre can be removed by lung macrophages;
(ii) a diameter less than about 3 mm, allowing the
ﬁbre to be inhaled to the gas-exchanging part
of the lung;
(iii) insolubility or resistance to dissolution in the
lung milieu;
(iv) a sufﬁcient dose to the target organ.
This has become known as the ﬁbre paradigm and is
very likely to apply to any inhaled ﬁbre. It seems that
the chemical composition of the ﬁbre is relatively unim-
portant other than as a determinant of its solubility
and that macrophages may ingest many short ﬁbres
without coming to harm. There is evidence, for
example, that the paradigm applies to ﬁbrous erionite,
to which individuals in Turkey suffering from asbestos-
type diseases have been exposed environmentally
(Artvinli & Baris 1982). The mechanism appears to
be frustrated phagocytosis, whereby the macrophage
is injured in attempting to engulf long ﬁbres and
releases cytokines, mitogens and oxidants that initiate
the process of ﬁbrosis and carcinogenesis. Experi-
mentally, similar consequences have been shown to
occur with other appropriately sized ﬁbres of different
compositions (Miller et al. 1999).
It is likely that the fact that human disease has not
been associated with these other ﬁbres reﬂects insuf-
ﬁcient doses having reached the target organs of
sufﬁcient individuals rather than any intrinsic lack of
toxicity. In part, this may be due to the awareness by
manufacturers of the determinants of toxicity and
deliberate design of ﬁbres to take account of this. In
the case of carbon nanotubes (CNTs) there is a lack
S122 Review. Nanoparticles, hazard and regulation A. Seaton et al.of knowledge on what proportion of airborne CNTs in
workplaces satisfy the length criterion of the ﬁbre para-
digm, since CNTs may be long but they frequently curl
up into tangled balls due to defects in the graphene
structure and interception by other CNTs. The nature
of the ‘particles’ that are formed means that they may
be physically large (possibly larger than 15 mm), with
high surface area but very low densities. Therefore,
they could have very low aerodynamic diameter and
could reach and deposit in the deep lung. It is not
at present known what toxic effect such particles
would have.
It is important to emphasize the difference between
hazard and risk, as illustrated above, and that preven-
tion of disease relies on prevention or reduction of
exposure and hence of dose to the target organ. Asbes-
tos has over many decades been inhaled by workers at
concentrations of several million in every cubic metre
of air breathed, is relatively insoluble and thus remains
in the lung long enough for many ﬁbres to migrate
through to the lung lining and initiate the process
that leads to mesothelioma. Dose, insolubility and
ﬁbre dimensions explain the epidemic of this cancer.
In contrast, at present, industrial exposure to most
other ﬁbres of appropriate size and shape has been
much more limited in both dose and duration (e.g.
Miller et al. 2007). Continued reduction in exposure is
the basis of action to prevent future problems.
Much debate has surrounded the possibility that
roughly spherical NPs may exert their toxic effects by
passage through epithelia and tissue membranes. This
has led to consideration that the ability to translocate
away from the site of deposition at the portal of entry
leads to new hazards from NPs. The idea that inhaled
NPs reach the blood, brain and other non-pulmonary
target organs is the basis of much of the concern
over manufactured NPs and the fear that existing risk
assessment instruments are inadequate. Most hazard
identiﬁcation studies that are used for risk assessment
do not include rigorous or sensitive analysis of cardio-
vascular or neurological endpoints that might be affected
by chronic exposure leading to the accumulation of NPs
in these sites.
The concept of translocation takes the ultraﬁne
hypothesis a step further, to propose that the toxic
effect of the particles is a consequence of a direct
action on the distal target organ rather than the one
mediated by cytokine release and secondary effects on
the target. Thus, it proposes that inhaled NPs pass
through the lungs’ alveolar membrane and go via the
blood to the heart where they exert a directly toxic
effect. This seems unlikely, ignoring as it does the
known mechanisms of myocardial infarction, the ampli-
ﬁcation effect of provoking an inﬂammatory reaction,
the dilutional effect of distribution through the blood
and the likely uptake of any blood-borne particles by
the reticulo-endothelial system. Nevertheless, some
studies have searched for and found NPs in various
organs including the heart following inhalation
exposure (Semmler et al. 2004). Such translocation is
small as a fraction of the deposited dose and has been
focused on model and surrogate particles such as
elemental carbon and iridium. So far, there are noJ. R. Soc. Interface (2010)data showing the translocation of environmental NPs
such as those generated by diesel combustion.
More plausible have been the observations with
respect to possible neurological effects of NPs. A
higher concentration of NPs is deposited on the
olfactory mucosa of the nose than elsewhere in the res-
piratory tract, where they are directly exposed to the
nerve endings concerned with smell. Oberdo¨rster et al.
(2004) have reasoned that, as polio viruses gain access
to the central nervous system, other nano-sized par-
ticles could be transmitted up the nerves into the
brain, with potential pathological effects. Such
migration has been suggested by studies on rats, but
there is as yet no convincing epidemiological evidence
associating air pollution with chronic brain diseases,
and the relevance of this remains sub judice.3.3. Inﬂammation and other mechanisms
Epidemiological studies have provided ample evidence,
mainly in the form of rises in C-reactive protein and
white blood cell count, that exposure to air pollution
is associated with a generalized inﬂammatory reaction
in the population being studied (Mills et al. 2009).
Chamber studies using concentrated ambient particles
have shown these particles to be mildly inﬂammagenic
as measured by a leucocyte response in alveolar ﬂuid
obtained by bronchoscopy (Ghio et al. 2000). Human
experimental studies have also shown increases in the
release of vasoconstrictor substances with exposure to
diesel exhaust, in this case without overt evidence of
an inﬂammatory reaction. It seems to us likely that
two or more mechanisms of toxicity are involved in
mediating the association of heart disease and particu-
late air pollution: (i) indirect effects of pulmonary
inﬂammation and oxidative stress on atherothrombosis
and (ii) translocation of particles to blood vessels and a
direct effect on their lining endothelial cells.
As noted above, longitudinal epidemiological studies
have shown an association between historic exposures to
pollution and later risk of developing a heart attack,
strongly suggesting that pollution exposure is a risk
factor for the development of arterial atheroma. Exper-
imental support for this has been provided by studies of
animals genetically predisposed to atheroma. The well-
documented cardiovascular impact of ambient particles
is considered to be a result of the combustion-derived
NP component. The high fat diet rabbit and ApoE
mouse model have been used extensively to demonstrate
that pulmonary exposure to particles causes plaque
expansion and increases in indices of plaque destabiliza-
tion (Suwa et al. 2002; Lippmann et al. 2005; Sun et al.
2005). Currently, there are only two studies of CNTs.
One showed evidence of oxidative stress in the aorta
and progression of atherosclerosis in ApoE mice after
a single pulmonary aspiration of single wall CNT (Li
et al. 2007). The other showed upregulation of gene
expression in aortic tissue after deposition of CNT in
mouse lungs (Erdely et al. 2009). For some genes,
this was orders of magnitude greater with CNT than
with carbon black, suggesting that CNT may have a
special action that affects the vessel wall. It is not
clear whether the CNTs themselves reach the aortic
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indirect inﬂammatory/oxidative stress mechanism,
although the latter is more plausible.4. TOXICITY OF MANUFACTURED
NANOPARTICLES
The predominant process underlying the pathological
effects of particles in the lungs and cardiovascular
system is inﬂammation, involved in atherothrombosis,
asthma, chronic obstructive lung disease, pulmonary
ﬁbrosis and cancer (Donaldson & Tran 2002). There-
fore, the ability of particles to initiate, prolong or
worsen inﬂammation can be seen as a key property.
Many studies have examined the pro-inﬂammatory
effects of manufactured NPs, on the basis that their
ability to cause inﬂammation is a major predictor of
potential hazard in such particles. The ﬁrst important
ﬁnding was that NPs have a more pronounced effect
on inﬂammation, cell damage and cell stimulation
than an equal mass of particles of the same material
of greater size (Donaldson et al. 2000). This appears
to hold true for materials as varied as carbon black,
titanium dioxide, various metals and polystyrene
(Dufﬁn et al. 2002). Surface area is the metric driving
the pro-inﬂammatory effects and this is evident both
in vitro (Donaldson & Tran 2002) and in vivo (Dufﬁn
et al. 2002), particles of various sizes producing inﬂam-
matory effects that are directly related to the surface
area dose. This surface area dose-related inﬂammatory
response is partly related to transition metals but is
also found with low-toxicity materials and the cellular
mechanism is not well understood. Even an apparently
low toxicity surface has the ability to generate free
radicals and oxidative stress in cells that has nothing
to do with transition metals, as there is no soluble
toxic component that could mediate the effect (Brown
et al. 2000, 2001). The low toxicity surface free radical
effect is evident in their ability to generate oxidants
in cell-free chemical systems (Brown et al. 2001;
Wilson et al. 2002). In cells, high surface area doses
appear to initiate inﬂammation through a number of
pathways but oxidative stress-responsive gene tran-
scription is one of the most important. Oxidative
stress is increased in cells exposed to some NP types
(Donaldson & Stone 2007) as well as activation of
oxidative stress-responsive transcription factors such
as NF-kB and AP-1 (Mroz et al. 2008). However, if
an NP has a reactive surface, soluble factors that are
pro-inﬂammatory (e.g. transition metals, organics
bioactivated to free radicals by the CyP450 system) or
a high aspect ratio, there could be effects additional
to that of simple total surface area (Donaldson et al.
2007; Poland et al. 2008; Wan et al. 2008; Stoeger
et al. 2009). A wide range of NPs has been found to
have the ability to cause pro-inﬂammatory effects
(Donaldson & Stone 2007) and mechanisms other
than the well-known ones described above may also be
operative for some NPs (Lu et al. 2009). Such toxico-
logical activities need to be resolved into an overarching
structure–activity relationship for NPs, requiring
collaboration between toxicology and surface science.J. R. Soc. Interface (2010)5. EXPOSURE TO MANUFACTURED
NANOPARTICLES
Hazardous materials will present risks to health only if
people are exposed to them. The Royal Society/Royal
Academy of Engineering report identiﬁed multiple
scenarios through which humans could become exposed
to engineered nanomaterials including occupational,
environmental and consumer exposure (Royal Society
and Royal Academy of Engineering 2004). In occu-
pational settings, exposure to NPs is plausible at all
phases of the material life cycle, although the nature,
level of exposure and the number of people involved
could differ greatly. During the development of a new
material, it is probable that this will occur under lab-
oratory conditions. Quantities produced and numbers
involved are likely to be small, but accidental releases
due to spills and accidents are a possibility. Later, in
commercial production, exposures may occur during
synthesis or in downstream activities such as recovery,
packaging, transport and storage. The quantities of
materials being handled will typically be much larger.
Depending on the speciﬁc properties of the new
material, it may be incorporated subsequently in a
range of other products or may be used in other pro-
cesses as a feed-stock material. All these scenarios
have the potential to result in exposure of people. NPs
may also be incorporated, for example, into a composite
material which may be subsequently re-engineered or
reprocessed, again with potential for exposure. Finally,
exposure may occur at the end of product life when
the material is disposed off. Hence, for a single material,
there are multiple potential exposure scenarios
depending on the details of its manufacture, use and
disposal.
Already more than 800 consumer products con-
taining NPs are listed on the Woodrow Wilson
database (http://www.nanotechproject.org/inventories/
consumer/). They include personal-care products such
as sunscreen and skin lotions, food additives, cleaning pro-
ducts, sealants and paints. In many of these, deliberate
exposure is intended, usually by ingestion or dermal
application. In other cases, incidental exposure, including
by inhalation, is clearly plausible (e.g. by spraying paint
containing NPs). Many types of NPs are incorporated
into these products; for example, zinc oxide and titanium
dioxide are incorporated into sunscreens, often at mass
concentrations greater than 10 per cent. The quantities
of NPs in other products are not usually clearly identiﬁed,
and identifying which products do contain NPs is
challenging, as there is no requirement for speciﬁc label-
ling. Nanosilver is one of the most commonly used NPs
in consumer products, particularly as a food supplement.5.1. Exposure metrics
Assessment of risk of harm to individuals requires
understanding of the inherent toxicity of the material
to which they are exposed and the dose delivered to
the target organ; dose is a function of exposure and
time, and assessing exposure requires measurements to
be made. In early studies of the health effects of inhaled
particles, dust samples were collected by drawing air
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lysed off-line to deﬁne estimates of exposure, expressed
as a concentration in air. For example, in early studies
in the coal industry, the samples were analysed by
counting particles collected on the ﬁlter under a light
microscope. This resulted in an estimate of exposure
in terms of particle number concentration, expressed
as number of particles per cubic centimetre or per
cubic metre of air. Epidemiological studies in that
industry later showed a good correlation between pneu-
moconiosis and mass concentration, expressed typically
as milligrams per metre cube. Assessment in terms of
mass was less demanding and more accurate than
manual counting under a microscope and so was the
preferred choice. Subsequently, the use of workplace
exposure limits (WELs), based on mass concentrations,
has become the norm for measuring or regulating
exposure for most hazardous chemicals or particles
(Health and Safety Executive 2005).
As discussed above, there is a growing view based on
the toxicological literature that possible health effects
arising from exposure to NPs may be better correlated
with surface area than with mass concentration. Par-
ticle number is also widely suggested as an appropriate
metric, based on the associations between particulate
air pollution and cardiovascular disease among older
people (Seaton et al. 1995). A structured review of
this issue has failed to ﬁnd sufﬁcient evidence to
select one metric in preference to others; it was
recommended that, where possible, mass, number and
surface area should all be measured (Maynard &
Aitken 2007).5.2. Studies of exposure in the workplace
Few studies so far have attempted to assess human
exposure to NPs in occupational situations. Exposure
to CNTs has been assessed in ﬁve studies, which
focused on laboratory-scale activities (Maynard et al.
2004; Methner et al. 2007; Bello et al. 2008, 2009; Han
et al. 2008). Two of these also looked at the potential
of aerosol release from cutting composites containing
CNTs (Methner et al. 2007; Bello et al. 2009). These
authors used a combination of methods including real-
time counting and systems to measure size, number,
mass and surface area concentrations together with
off-line image analysis of collected samples by electron
microscopy. All found some evidence of exposure
under some circumstances, though in all save one ﬁbre
release was not identiﬁed. Only one study used ﬁbre-
counting methods based on those required for the
measurement of asbestos in occupational settings
(Han et al. 2008), reporting concentrations of 194 and
173 ﬁbres ml21 associated with blending and mixing
activities, based on both personal and area samples.
While these are three orders of magnitude greater
than typical asbestos WELs of 0.1 ﬁbres ml21, all the
ﬁbres were too short to be considered a ﬁbre under
the World Health Organization (WHO) criteria, the
reported maximum length observed being 1500 nm, in
contrast to the WHO minimum of 5000 nm (World
Health Organization 1997). Enclosure of the blendingJ. R. Soc. Interface (2010)activity reduced the ﬁbre count by four orders of
magnitude, indicating effective control of ﬁbre release.
With respect to non-ﬁbrous particles, one study at a
pilot scale ‘nanostructured particle’ gas phase metal
oxide production facility showed elevated number con-
centrations during production rising to an order of
magnitude higher than background levels (Demou
et al. 2008). Another assessed airborne NP exposures
associated with manual handling of small quantities
(15 and 100 g) of nano-alumina and nanosilver in
fume hoods (Tsai et al. 2009). Using a conventional
fume hood, particle number concentration in the oper-
ator’s breathing zone increased signiﬁcantly during
the 100 g handling, peak concentrations at 10 and
200 nm being reported, varying according to activity,
A third study characterized airborne particle concen-
trations during the production of carbonaceous
nanomaterials, including fullerenes and CNTs, in a
commercial facility (Yeganeh et al. 2008). Mass con-
centrations, sub-micrometre size distributions and
photoionization potential (an indicator of the particles’
carbonaceous content) were measured at three
locations inside the facility. Rises in concentration
were associated with physical handling of the particles.
A number of common features may be identiﬁed. For
air velocities prevailing in workplaces, airborne NPs can
be considered as having no inertia. They will therefore
behave like a gas, will diffuse rapidly and remain air-
borne for a long time. Because of their high diffusion
velocity, these particles will readily ﬁnd leakage paths
in systems in which the containment is not complete.
Engineering control systems for NPs, such as enclo-
sures, local ventilation or general ventilation, therefore
need to be of similar quality and speciﬁcation to those
normally used for gases rather than for particulate
matter. As with all such systems, effective performance
is dependent on the appropriate use and maintenance.
Several of the studies discussed above have considered
the effectiveness of the control systems. In general,
these have been shown to be broadly effective, exposure
occurring where the systems are not used properly, are
defective or have been deliberately disabled (Han
et al. 2008).
Filtration theory indicates that commercial respirator
ﬁlters should be efﬁcient collectors of NPs owing to cap-
ture by diffusion (Aitken et al. 2004). Conventional
theory suggests that the most penetrating particle size
is likely to be of the order of 300–500 nm, which rep-
resents a minimum between the mechanisms of diffusion
(greater for smaller particles) and impaction (greater for
larger particles). A study investigating ﬁltration per-
formance of standard ﬁltering facepiece respirators
against monodisperse silver aerosol particles in the
range of 4–30 nm diameter showed a decrease in percen-
tage penetration with decrease in particle diameter down
to 4 nm (Rengasamy et al. 2008). This efﬁcient perform-
ance of the ﬁlter does not, however, take account of
leakage around the facepiece, which is likely to be the
primary issue in relation to respirator performance.
It is obvious that fugitive emissions from processes in
which nanomaterials are produced could lead to
increased air concentration of these nanomaterials. As
well as environmental exposure in these circumstances,
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One application that could lead to the exposure of the
general population is the use of cerium oxide as a fuel
additive. Potential concentrations in air have been esti-
mated, based on the assumptions about the quantity of
cerium oxide present in fuel and the uptake of fuel con-
taining cerium oxide, using dispersion models developed
and validated by the Highways Agency (Boxall et al.
2007). Using a mix of trafﬁc type with trafﬁc ﬂow at
40 km h21 and at 1000 vehicles per day, they estimated
a cerium oxide concentration at a distance of 5 m from
the road of 0.0006 mg m23, a very low mass concen-
tration. Their estimate, however, did not take into
account the number concentration or standing trafﬁc
in congested city centre streets. They also used a
simple modelling approach to estimate possible consu-
mer exposure by inhalation and dermal exposure from
spray-on sunscreen. They estimated that an inhalation
NP exposure concentration of 35 mg m23 was plausible.
Even in an occupational context, this would be a high
concentration, although the duration of exposure
would be very short. They also estimated that approxi-
mately 3 g might be applied daily, which would give a
skin coverage of about 1 mg cm22. Of this, approxi-
mately 5 per cent is the NP ingredient. Although very
few materials have an occupational skin exposure
limit, this again would be a non-trivial exposure, even
in mass terms.6. A THEORETICAL APPROACH TO
RISK ASSESSMENT
6.1. Hazard identiﬁcation
From thermodynamic principles, it is logical to
conclude that surface reactivity may change with
particle size for any material and that the unit mass
and chemical reactivity (as well as thermodynamic
instability) of a compound increases as particle size
decreases. However, the possible pathogenic mechan-
isms induced by particle exposure are very complex,
depending on the route of exposure, dose, host response,
susceptibility and the speciﬁc physico-chemical
properties of the individual particles. The primary NP
exposure can be to the lungs, skin or gut but transloca-
tion to other target organs raises the possibility that
different mechanisms of toxicity, dependent on the
target organ, can operate. For example, redox con-
ditions vary from highly oxidizing on the skin or in
the lung to highly reducing in the intestine or interstitial
sites; this could have an important impact on oxidative
stress-driven mechanisms. Thus, for a proper assessment
of engineered NP hazard, it is necessary to focus on all
the body systems that are potential targets for NPs.6.2. Tools for hazard assessment
The current quantitative support tools for investigation
are speciﬁed in the Organization for Economic
Cooperation and Development (OECD) guideline and
the new European Union regulatory framework
REACH (Registration, Evaluation and Authorisation
of Chemicals). They are (i) standard regulatoryJ. R. Soc. Interface (2010)toxicology tests, (ii) quantitative structure–activity
relationship (QSAR), and (iii) physiologically based
pharmacokinetics models (PBPK).
6.2.1. Regulatory toxicology tests. The OECD guideline
for the testing of chemicals has been implemented for
many toxicological endpoints. Of relevance to NPs are
the acute and subchronic inhalation toxicity tests.
The main limitations of these tests are: some toxic
endpoints are not relevant to nanotoxicology (e.g.
LC50); the difﬁculty in aerosolizing NPs owing to
their fast rate of agglomeration and the extensive use
of animals for testing. The OECD is currently
considering an alternative testing strategy for
nanomaterials and non-inhalation toxicity tests in the
spirit of reducing the need for animal experiments.
6.2.2. Quantitative structure–activity relationship. The
aim of a QSAR model is to understand the properties of
a chemical that inﬂuence its biological activity and to be
able to predict the activity of previously untested
structures/compounds. The use of a toxicity-based
QSAR is a well-established approach for predicting the
toxicity of chemicals for a wide variety of endpoints.
The growing importance of in silico methods such as
QSARs for providing information about toxicity is
reﬂected in a number of regulatory frameworks (e.g.
REACH) where these approaches are considered
acceptable methods under certain conditions for ﬁlling
in knowledge gaps for untested chemicals. The
increasing production of novel formulations of NPs by
industry poses an immediate problem for hazard and
risk assessment, as many of them remain untested and
thus QSARs, and in silico tools, in general, are highly
desirable methods to predict their toxicity.
6.2.3. Pharmacokinetic models. There is currently no
established PBPK model for the distribution of NPs
in the body. NPs are larger than most molecules and
the standard pharmacokinetics model transport
equations need to be re-examined to assess their
validity for particles. An NP model is essential for
describing the exposure–dose–response relationship
and extrapolation of this relationship between species.
6.2.4. In vitro– in vivo extrapolation. Information on
the toxicity of chemicals can be obtained more efﬁciently
in in vitro experiments than in vivo but translation of the
results is a major issue. Dose–response modelling is
required both for quantitative comparisons of in vitro
with in vivo studies and to compare different in vitro
studies.
6.3. Exposure assessment
The very limited data on exposure to nanomaterials in
an occupational or consumer context are discussed
above. The most obvious difﬁculties relate to identiﬁ-
cation of small mass quantities of emission and of
measuring number or surface area of emissions in a
background of normal ambient particles which com-
monly may be hundreds of thousands of particles per
millilitre. Likely expenses of monitoring such emissions
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the particles prove unusually toxic, and a similar argu-
ment may apply to methods of containment and worker
protection. Nevertheless, there are important scientiﬁc
challenges in devising instruments that could be used
both in toxicology and in environmental monitoring
for measuring NPs. These challenges exist both in
measuring NPs in media such as air to which people
are exposed and in measuring the appropriate metric
for dose when examining target organs in toxicology.
Response to these challenges depends on collaboration
between designers, industrial hygienists and toxicolo-
gists if the biologically relevant metric is to be
measured, because this is at present still unknown.
6.4. Risk assessment
Different approaches to assess the health risk for
manufactured NPs have been proposed, such as a tool
for risk-level assessment and control of NP exposure.
However, a quantitative risk assessment of NPs is not
yet possible. The traditional risk assessment process
outlined by REACH involves the use of toxicology
data to obtain the derived no-effect level (DNEL) of
exposure. Risk is assessed by comparing the DNEL
with the exposure levels obtained from the different
scenarios in the exposure assessment.7. REGULATION: CODES OF CONDUCT
AND LEGISLATION
Despite the wide range of potential exposure situations
and therefore potential risks, speciﬁc regulation has
been slow to emerge. One of the issues here is that
because of the breadth of applications, from paints to
cosmetics to medicines, many different regulatory fra-
meworks apply. For example, in Europe, this would
include regulations on worker safety, chemicals, general
products, cosmetics, food, pollution, biocides, water,
waste and labelling. However, reviews of regulations,
for example the BRASS report in the UK (Frater
et al. 2006), have consistently reported that, while the
regulatory framework is capable of dealing with nano
issues, the regulations are not well attuned to dealing
with the speciﬁcs of nano-sized materials. Few refer to
particle size as a factor to be considered. In many
cases, there is nothing within the regulations that
would trigger any need for change of notiﬁcation
requirements if a macro-sized material is replaced by a
nano-sized one of the same chemical. In some cases,
for example, the REACH regulations, the ‘trigger
points’, in terms of production mass which would
necessitate additional action, are high relative to the
probable quantities of NPs which would be produced.
For many types of consumer products, almost no
testing is necessary before they enter the market.
Whether this situation continues remains to be seen.
A recent motion passed by the European Parliament
has been critical of the current situation and has
called on the Commission to review all relevant legis-
lation within 2 years to ensure safety for all applications
of nanomaterials in products with potential health,
environmental or safety impacts over their life cycleJ. R. Soc. Interface (2010)and to ensure that legislative provisions and instru-
ments of implementation reﬂect the particular features
of nanomaterials to which workers, consumers and/or
the environment may be exposed. On a more positive
note, there has been an increase in the guidance made
available, and codes of conduct have emerged intended
to provide a basis by which companies and others man-
ufacturing or using NPs can align themselves with the
principles of good practice. The European Commission
has published a recommendation aimed at all those
involved in nanotechnology research including funding
organizations, industry, academic groups and research-
ers themselves. The code recognizes many of the
uncertainties involved and comprises a general exhorta-
tion towards good practice. It is based on a set of
general principles that call for actions aimed at guaran-
teeing their respect by all stakeholders. Among these is
the principle that ‘research activities should be con-
ducted in accordance with the precautionary principle,
anticipating potential environmental, health and safety
impacts of nanoscience and nanotechnology outcomes
and taking due precautions, proportional to the level
of protection’. The code also recommends that ‘As
long as risk assessment studies on long-term safety are
not available, research involving deliberate intrusion
of nano-objects into the human body, their inclusion
in food (especially in food for babies), feed, toys,
cosmetics and other products that may lead to exposure
to humans and the environment, should be avoided’.
And, ﬁnally, the code states that ‘Students, researchers
and research organisations involved in nanoscience and
nanotechnology research should take speciﬁc health,
safety and environmental measures adapted to the par-
ticularities of the nano-objects manipulated. Speciﬁc
guidelines on the prevention of pathologies induced
by nano-objects should be developed in line with the
Community Strategy 2007–2014 on Health and Safety
at Work’.
It remains to be seen how effective this code will be or
how many national or industry organizations will
adhere to its principles.
In the UK, the Health and Safety Executive (HSE) has
recently published guidance on safe handling of CNTs.
The HSE views CNTs as being substances of very high
concern and have stated that a ‘precautionary approach
should be taken to the risk management of all CNTs,
unless sound documented evidence is available on the
hazards from breathing in CNTs’. If their use cannot be
avoided, the HSE expects a high level of control to
be used including a recommendation to control exposure
at source by carrying out all tasks, including packaging
for disposal, in a ducted fume cupboard with a high efﬁ-
ciency particulate air (HEPA) ﬁlter, or by using other
suitable effective local exhaust ventilation with a HEPA
ﬁlter (www.hse.gov.uk/pubns/web38.pdf). Other more
general guidance has been provided by the British
Standards Institute that has published the ﬁrst extensive
guide to safe handling of nanomaterials (British
Standards Institute 2009). This document provides step-
by-step guidance to the general approach to management
of risks, information needs, hazard assessment, measure-
ment of exposure, methods of control and disposal. It is
intended to help manufacturers and users work with
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downloaded free from www.bsi.com/nano. Other web-
based resources such as SAFENANO (www.safenano.
org) are also available to help guide those unfamiliar
with these issues.8. LESSONS FOR NANOTECHNOLOGY
AND NANOTOXICOLOGY RESEARCH
Consideration of the above issues leads to the con-
clusion that NPs (which after all are produced because
their small size confers certain advantageous chemical
or physical properties) might have different actions in
biological systems from those of the same material at
larger dimensions and that in some cases these may
lead to unexpected toxic effects. It should, however,
be borne in mind that workers with industrial diseases
have usually been exposed to high doses of the materials
over years; dose is critical in determining toxicity and
dose is the product of concentration and duration of
exposure. A fundamental method of avoiding harm is
thus reduction or complete prevention of exposure,
and this should be the aim of regulation of any NP
considered likely to be toxic. We have outlined the
fundamental elements of an integrated risk assessment
approach. This approach originated from the assess-
ment of health risks for chemicals and is currently
adopted for manufactured NPs. An important
limitation of this approach is that it is likely to produce
estimates of no-effect levels that are too low to be dis-
tinguishable from the background level of exposure to
airborne particles. Where it is not feasible to control
exposure to an appropriate level, it is sensible to explore
the possibility of hazard reduction. Current nanotoxico-
logical research aims to identify the physico-chemical
characteristics of NPs responsible for the observed
health effects. These results could be incorporated in
the design of new engineered NPs. The challenge is to
produce new nanomaterials that are without adverse
characteristics and still fulﬁl the industrial require-
ments. This approach would have the advantage of
initiating a sustainable and safe nanotechnology.
Thus, two parallel streams of research are desirable:
to understand the toxic properties of a range of NPs
and to develop methods of assessing this toxicity
in vitro and to investigate exposure scenarios in the
likely life cycles of the materials being developed for
the market. Both are complex, and some of the issues
surrounding life cycle analysis are discussed above
(§5). With respect to understanding the toxicity of
NPs, the ﬁeld of nanotechnologies involving particles
is expanding rapidly and funding for the desirable
range of research (Maynard et al. 2006) is likely to
remain limited. Thus, research should aim at under-
standing fundamental issues relating surface activity
and interaction with biological structures and systems,
with the objective of determining structure–activity
relationships that may be generalized for the design of
new particles. Speciﬁc issues of toxicity of an individual
NP should remain the responsibility of those who man-
ufacture them. From this arises a second difﬁculty:
what toxicological tests are appropriate for assessingJ. R. Soc. Interface (2010)new NPs? For nanotubes, it is probably sufﬁcient to
assume that they conform to the ﬁbre paradigm
(Poland et al. 2008), and thus if single long ﬁbres are
likely to be released into the air, they should be treated
as asbestos without the need for further toxicology. If it
can be shown that they do not release single ﬁbres, they
may be treated as non-ﬁbrous particles. In this respect,
as noted before, bundles of nanotubes will have a much
larger surface area and lower aerodynamic diameter
than similar-sized solid particles and thus pose particular
difﬁculties to phagocytic cells, with as yet undeter-
mined toxicological consequences. For other engineered
NPs, standard toxicological testing, with its emphasis
on carcinogenicity and foetal toxicity, is probably
irrational and appropriate tests of inﬂammatory potential
and endothelial activation need to be developed in order
to detect those that might entail hazard. A third issue is
the complex problem of biologically relevant measure-
ment as mentioned below, and which is desirable both
to understanding the toxicology of NPs and to assessing
them in the workplace.
The most encouraging results of research in this ﬁeld
to date relate to those on containment and control of
exposure. No one suffers adverse effects in the absence
of exposure and measures to prevent exposure are neither
more nor less complex than those required to prevent
exposure to gases. Methods for ensuring this in research
and production are available and may require to be used
in cases where toxic effects might reasonably be antici-
pated. However, the widespread use of NPs in consumer
products does give cause for concern, especially when
these may be inhaled, ingested or applied to body sur-
faces. Deﬁnitions of what is an NP, what proportion is
allowable in any mixture, how to measure and label it
and how to enforce regulation present formidable
problems for regulators. It would not surprise us if
unexpected toxic effects, perhaps in relation to inhalation
accidents, skin allergies or intestinal problems, were to
come to light as a result of unregulated introduction of
such particles into consumer products.
A ﬁnal area of research need relates to measurement.
There does not at present seem to be an alternative to
counting ﬁbres of appropriate dimensions for control
of exposure to CNT, using the internationally agreed
methods for asbestos, with electron microscopy. With
respect to other non-ﬁbrous particles, although the evi-
dence is at present insufﬁcient, on general principles it
seems likely that a measure of surface area of an aerosol
will prove the most useful. An instrument that measures
this in real time that could be deployed as a personal
sampler in workplaces is perhaps as good as could be
achieved in the short term. As a longer term objective,
an instrument might be developed that is able also to
measure the toxic potential of the aerosol directly.
This is a challenge to collaborate across the areas of
instrument design, surface chemistry and toxicology.REFERENCES
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